MedTrace Logo

Cancer Patients Treated With Immunotherapy in Intensive Care Unit

NCT03357861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-26

No results posted yet for this study

Summary

This work aims to describe the characteristics and methods of management of patients suffering from a solid tumor treated with immunotherapy admitted to intensive care.

Conditions

  • Cancer
  • Critical Illness
  • Immunotherapy

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

  • Jules Bordet Institute

    collaborator OTHER

Principal Investigators

  • Anne-Claire TOFFART, MD-PhD · UniversityHospital Grenoble

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-08-23
Completion
2021-08-23

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03357861 on ClinicalTrials.gov